First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Sign Up to like & getrecommendations! Published in 2021 at "Nature Medicine"
DOI: 10.1038/s41591-021-01408-4
Abstract: Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events have led to some countries restricting its use. Using a national prospective cohort, we estimated associations between exposure to first-dose ChAdOx1 or BNT162b2 vaccination and hematological… read more here.
Keywords: first dose; chadox1; thromboembolic hemorrhagic; dose chadox1 ... See more keywords
Development and Validation of a Risk Scoring System for Cephamycin-Associated Hemorrhagic Events
Sign Up to like & getrecommendations! Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-49340-5
Abstract: Cephamycin-associated hemorrhages have been reported since their launch. This research aimed to determine risk factors for cephamycin-associated hemorrhagic events and produce a risk scoring system using National Taiwan University Hospital (NTUH) database. Patients who were… read more here.
Keywords: risk; scoring system; risk scoring; cephamycin associated ... See more keywords
Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
Sign Up to like & getrecommendations! Published in 2021 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2021-017615
Abstract: Background Stratification of the risk of hemorrhage in patients with acute ischemic stroke following dual antiplatelet therapy (DAPT) is challenging. It remains unclear whether thromboelastography (TEG) can be used to predict DAPT-related hemorrhagic events. Objective… read more here.
Keywords: ischemic stroke; patients acute; acute ischemic; hemorrhage ... See more keywords